Search research articles
Contact Us
Filters
Showing results (11-20 of 24) with videos related to
Page
of 3
Sort By:
Tropical Medicine and Infectious Disease
|
November 13, 2020
AAV Vectored Immunoprophylaxis for Filovirus Infections
Amira D Rghei, Laura P van Lieshout, Lisa A Santry, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 13, 2018
Combining Vascular Normalization with an Oncolytic Virus Enhances Immunotherapy in a Preclinical Model of Advanced-Stage Ovarian Cancer
Kathy Matuszewska, Lisa A Santry, Jacob P van Vloten, et al.
BMC Biotechnology
|
June 20, 2020
Interference chromatography: a novel approach to optimizing chromatographic selectivity and separation performance for virus purification
Lisa A Santry, Renaud Jacquemart, Melissa Vandersluis, et al.
Molecular Therapy. Methods & Clinical Development
|
November 17, 2021
Production and purification of high-titer OrfV for preclinical studies in vaccinology and cancer therapy
Jacob P van Vloten, Jessica A Minott, Thomas M McAusland, et al.
Molecular Therapy. Methods & Clinical Development
|
August 17, 2018
Use of Precision-Cut Lung Slices as an <i>Ex Vivo</i> Tool for Evaluating Viruses and Viral Vectors for Gene and Oncolytic Therapy
María C Rosales Gerpe, Jacob P van Vloten, Lisa A Santry, et al.
Frontiers in Microbiology
|
February 8, 2024
Recombinant Newcastle disease viruses expressing immunological checkpoint inhibitors induce a pro-inflammatory state and enhance tumor-specific immune responses in two murine models of cancer
Lisa A Santry, Jacob P van Vloten, Amanda W K AuYeung, et al.
Cytokine & Growth Factor Reviews
|
September 7, 2020
Tumour vasculature: Friend or foe of oncolytic viruses?
Lisa A Santry, Jacob P van Vloten, Jason P Knapp, et al.
Gene Therapy
|
February 2, 2023
Antibody-based protection against respiratory syncytial virus in mice and their offspring through vectored immunoprophylaxis
Amira D Rghei, Jacob G E Yates, Jordyn A Lopes, et al.
Molecular Therapy Oncolytics
|
December 11, 2023
Kinetic analysis of oncolytic OrfV-induced innate and adaptive immune responses in a murine model of late-stage ovarian cancer
Jessica A Minott, Jacob P van Vloten, Jake G E Yates, et al.
Molecular Therapy Oncolytics
|
February 22, 2021
Combining vanadyl sulfate with Newcastle disease virus potentiates rapid innate immune-mediated regression with curative potential in murine cancer models
Thomas M McAusland, Jacob P van Vloten, Lisa A Santry, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 24) with videos related to
Sort By:
Page
of 3
Tropical Medicine and Infectious Disease
|
November 13, 2020
AAV Vectored Immunoprophylaxis for Filovirus Infections
Amira D Rghei, Laura P van Lieshout, Lisa A Santry, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 13, 2018
Combining Vascular Normalization with an Oncolytic Virus Enhances Immunotherapy in a Preclinical Model of Advanced-Stage Ovarian Cancer
Kathy Matuszewska, Lisa A Santry, Jacob P van Vloten, et al.
BMC Biotechnology
|
June 20, 2020
Interference chromatography: a novel approach to optimizing chromatographic selectivity and separation performance for virus purification
Lisa A Santry, Renaud Jacquemart, Melissa Vandersluis, et al.
Molecular Therapy. Methods & Clinical Development
|
November 17, 2021
Production and purification of high-titer OrfV for preclinical studies in vaccinology and cancer therapy
Jacob P van Vloten, Jessica A Minott, Thomas M McAusland, et al.
Molecular Therapy. Methods & Clinical Development
|
August 17, 2018
Use of Precision-Cut Lung Slices as an <i>Ex Vivo</i> Tool for Evaluating Viruses and Viral Vectors for Gene and Oncolytic Therapy
María C Rosales Gerpe, Jacob P van Vloten, Lisa A Santry, et al.
Frontiers in Microbiology
|
February 8, 2024
Recombinant Newcastle disease viruses expressing immunological checkpoint inhibitors induce a pro-inflammatory state and enhance tumor-specific immune responses in two murine models of cancer
Lisa A Santry, Jacob P van Vloten, Amanda W K AuYeung, et al.
Cytokine & Growth Factor Reviews
|
September 7, 2020
Tumour vasculature: Friend or foe of oncolytic viruses?
Lisa A Santry, Jacob P van Vloten, Jason P Knapp, et al.
Gene Therapy
|
February 2, 2023
Antibody-based protection against respiratory syncytial virus in mice and their offspring through vectored immunoprophylaxis
Amira D Rghei, Jacob G E Yates, Jordyn A Lopes, et al.
Molecular Therapy Oncolytics
|
December 11, 2023
Kinetic analysis of oncolytic OrfV-induced innate and adaptive immune responses in a murine model of late-stage ovarian cancer
Jessica A Minott, Jacob P van Vloten, Jake G E Yates, et al.
Molecular Therapy Oncolytics
|
February 22, 2021
Combining vanadyl sulfate with Newcastle disease virus potentiates rapid innate immune-mediated regression with curative potential in murine cancer models
Thomas M McAusland, Jacob P van Vloten, Lisa A Santry, et al.
Page
of 3